Portugal

How cheap Chinese antibiotics threaten the last major penicillin factory in Europe

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 22/10/2026, 20:50:25 UTC.

Briefings

A Chinese quota for EU penicillin imports surged from 44% in 2019 to 86% the previous year, threatening the last major European penicillin factory. The evidence indicates a significant shift in import dependency, with China controlling the vast majority of EU penicillin imports under active pharmaceutical ingredients. This change represents a critical supply chain vulnerability for European pharmaceutical production.

Key points

• China's quota for EU penicillin imports increased from 44% in 2019 to 86% in the previous year.
• The quota increase was driven primarily by active pharmaceutical ingredients, not penicillin itself.

Context

This finding highlights a critical shift in global pharmaceutical supply chains, where China's dominance in EU imports has grown substantially, potentially threatening European pharmaceutical production capabilities.

Limitations

The evidence is limited to a single data point regarding quota percentages for active pharmaceutical ingredients. No specific dates for the quota increase, names of affected factories, or reasons for the quota shift are provided in the source.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 23/10/2026, 02:17:34 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeic5ch7masw2yg5up4b6ttavrwktdaimj7qzn7fwf7vl37dmygj5wu